1. Home
  2. CTOR vs SOL Comparison

CTOR vs SOL Comparison

Compare CTOR & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • SOL
  • Stock Information
  • Founded
  • CTOR 2021
  • SOL 2005
  • Country
  • CTOR United States
  • SOL United States
  • Employees
  • CTOR N/A
  • SOL N/A
  • Industry
  • CTOR
  • SOL Semiconductors
  • Sector
  • CTOR
  • SOL Technology
  • Exchange
  • CTOR NYSE
  • SOL Nasdaq
  • Market Cap
  • CTOR 89.9M
  • SOL 84.6M
  • IPO Year
  • CTOR N/A
  • SOL 2008
  • Fundamental
  • Price
  • CTOR $0.67
  • SOL $1.26
  • Analyst Decision
  • CTOR Strong Buy
  • SOL Buy
  • Analyst Count
  • CTOR 2
  • SOL 3
  • Target Price
  • CTOR $4.50
  • SOL $3.50
  • AVG Volume (30 Days)
  • CTOR 3.9M
  • SOL 218.6K
  • Earning Date
  • CTOR 05-21-2025
  • SOL 05-22-2025
  • Dividend Yield
  • CTOR N/A
  • SOL N/A
  • EPS Growth
  • CTOR N/A
  • SOL N/A
  • EPS
  • CTOR N/A
  • SOL N/A
  • Revenue
  • CTOR N/A
  • SOL $92,067,000.00
  • Revenue This Year
  • CTOR N/A
  • SOL N/A
  • Revenue Next Year
  • CTOR N/A
  • SOL $45.37
  • P/E Ratio
  • CTOR N/A
  • SOL N/A
  • Revenue Growth
  • CTOR N/A
  • SOL N/A
  • 52 Week Low
  • CTOR $0.55
  • SOL $1.04
  • 52 Week High
  • CTOR $49.00
  • SOL $3.00
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • SOL 38.04
  • Support Level
  • CTOR N/A
  • SOL $1.16
  • Resistance Level
  • CTOR N/A
  • SOL $1.46
  • Average True Range (ATR)
  • CTOR 0.00
  • SOL 0.11
  • MACD
  • CTOR 0.00
  • SOL -0.03
  • Stochastic Oscillator
  • CTOR 0.00
  • SOL 20.00

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.

Share on Social Networks: